Rationale and design of a study to evaluate effects of pitavastatin on Japanese patients with chronic heart failure: The pitavastatin heart failure study (PEARL study)

International Journal of Cardiology

Volumn 156, Issue 2, 2012, Pages 144-147

  Mizuma, Hiroshi ^a   Inoue, Teruo ^b   Takano, Hiroyuki ^a   Shindo, Satoshi ^a   Oka, Toru ^a   Fujimatsu, Daisuke ^c   Kuwabara, Yoichi ^a   Node, Koichi ^c   Komuro, Issei ^a  

^a CHIBA UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c SAGA UNIVERSITY   (Japan)

Author keywords

Chronic heart failure; Hypercholesterolemia; Randomized controlled trial; Statin

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PITAVASTATIN; PLACEBO;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHRONIC DISEASE; DEATH; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUINOLINES; TREATMENT OUTCOME;

EID: 84858299039     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.10.022     Document Type: Article

References (36)

1. J.C. LaRosa, J. He, and S. Vupputuri Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials JAMA 282 1999 2340 2346 (Pubitemid 30013066)
2. M. Pignone, C. Phillips, and C. Mulrow Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials BMJ 321 2000 983 986
3. T.J. Wilt, H.E. Bloomfield, and R. MacDonald Effectiveness of statin therapy in adults with coronary heart disease Arch Intern Med 164 2004 1427 1436 (Pubitemid 38937854)
4. C. Baigent, A. Keech, and P.M. Kearney Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
5. K. Ramasubbu, J. Estep, D.L. White, A. Deswal, and D.L. Mann Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy J Am Coll Cardiol 51 2008 415 426
6. S. Ichihara, A. Noda, and K. Nagata Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure Cardiovasc Res 69 2006 726 735 (Pubitemid 43139735)
7. V. Zacà, S. Rastogi, and M. Imai Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure J Am Coll Cardiol 50 2007 551 557 (Pubitemid 47126770)
8. M. Yoshida, I. Shiojima, H. Ikeda, and I. Komuro Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity J Mol Cell Cardiol 47 2009 698 705
9. J. Shepherd, G.J. Blauw, and M.B. Murphy Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial Lancet 360 2002 1623 1630 (Pubitemid 35379733)
10. D. Mozaffarian, R. Nye, and W.C. Levy Statin therapy is associated with lower mortality among patients with severe heart failure Am J Cardiol 93 2004 1124 1129 (Pubitemid 38521041)
11. T.B. Horwich, W.R. MacLellan, and G.C. Fonarow Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure J Am Coll Cardiol 43 2004 642 648 (Pubitemid 38229538)
12. A.S. Go, W.Y. Lee, J. Yang, J.C. Lo, and J.H. Gurwitz Statin therapy and risks for death and hospitalization in chronic heart failure JAMA 296 2006 2105 2111 (Pubitemid 44664705)
13. K. Node, M. Fujita, M. Kitakaze, M. Hori, and J.K. Liao Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy Circulation 108 2003 839 843 (Pubitemid 37022126)
14. D. Mozaffarian, E. Minami, R.A. Letterer, R.L. Lawler, G.B. McDonald, and W.C. Levy The effects of atorvastatin (10 mg) on systemic inflammation in heart failure Am J Cardiol 96 2005 1699 1704 (Pubitemid 41790394)
15. D. Tousoulis, C. Antoniades, and C. Vassiliadou Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure Eur J Heart Fail 7 2005 1126 1132 (Pubitemid 41721115)
16. R. Wojnicz, K. Wilczek, and E. Nowalany-Kozielska Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels Am J Cardiol 97 2006 899 904
17. S. Sola, M.Q. Mir, S. Lerakis, N. Tandon, and B.V. Khan Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure J Am Coll Cardiol 47 2006 332 337 (Pubitemid 43063250)
18. J. Kjekshus, E. Apetrei, and V. Barrios Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2007 2248 2261 (Pubitemid 350190755)
19. L. Tavazzi, A.P. Maggioni, and R. Marchioli Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 372 2008 1231 1239
20. N.A. Flores Pitavastatin Nissan/Kowa Yakuhin/Novartis/Sankyo Curr Opin Investig Drugs 3 2002 1334 1341
21. Y. Saito, N. Yamada, and T. Teramoto A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia Atherosclerosis 162 2002 373 379 (Pubitemid 34457943)
22. P. Iglesias, and J.J. Díez New drugs for the treatment of hypercholesterolaemia Expert Opin Investig Drugs 12 2003 1777 1789 (Pubitemid 37408126)
23. S.D. Anker, A.L. Clark, and R. Winkler Statin use and survival in patients with chronic heart failure-results from two observational studies with 5200 patients Int J Cardiol 112 2006 234 242 (Pubitemid 44376681)
24. P.S. Sever, B. Dahlöf, and N.R. Poulter Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled tria Lancet 361 2003 1149 1158 (Pubitemid 36398384)
25. M. Rauchhaus, A.J. Coats, and S.D. Anker The endotoxin-lipoprotein hypothesis Lancet 356 2000 930 933
26. M. Turunen, J. Olsson, and G. Dallner Metabolism and function of coenzyme Q Biochim Biophys Acta 1660 2004 171 199 (Pubitemid 38125244)
27. G.P. Littarru, and L. Tiano Bioenergetic and antioxidant properties of coenzyme Q10: recent developments Mol Biotechnol 37 2007 31 37 (Pubitemid 350135901)
28. R.Y. Mukhtar, J. Reid, and J.P. Reckless Pitavastatin Int J Clin Pract 59 2005 239 252 (Pubitemid 40331227)
29. K. Kajinami, H. Mabuchi, and Y. Saito NK-104: a novel synthetic HMG-CoA reductase inhibitor Expert Opin Investig Drugs 9 2000 2653 2661
30. I.P. Hargreaves, A.J. Duncan, S.J. Heales, and J.M. Land The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications Drug Saf 28 2005 659 676 (Pubitemid 41132454)
31. M.A. Kawashiri, A. Nohara, and H. Tada Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover study Clin Pharmacol Ther 83 2008 731 739 (Pubitemid 351556020)
32. S. Morikawa, M. Umetani, and S. Nakagawa Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells J Atheroscler Thromb 7 2000 138 144
33. H. Fujino, T. Saito, Y. Tsunenari, and J. Kojima Interaction between several medicines and statins Arzneimittelforschung 53 2003 145 153 (Pubitemid 36363609)
34. K. Kim, J.A. Johnson, and H. Derendorf Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms J Clin Pharmacol 44 2004 1083 1105 (Pubitemid 39202454)
35. J.K. Liao Safety and efficacy of statins in Asians Am J Cardiol 99 2007 410 414 (Pubitemid 46149563)
36. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150